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Abstract
Aim: Rectus sheath hematoma is a rare clinical condition. Because it could mimic various intra-abdominal pathologies suspicious approach and attention is 
needed for proper diagnosis and management of rectus sheath hematoma. The aim of this study is a review of factors affecting mortality in patients with 
rectus sheath hematoma besides clinical features, diagnosis modalities, treatment periods and results of patients with rectus sheath hematoma. Material and 
Method: Twenty-three patients with rectus sheath hematoma from January 2012 to March 2017 in a tertiary care center were included in the study. Patients’ 
files were reviewed retrospectively. Reviewed variables were demographic and clinical features, symptom and findings, co-morbidities, medications, laboratory 
findings, diagnostic modalities, APACHE II scores, treatment approaches, transfused blood products and length of hospital stay. Results: Fifteen (65.2%) of the 
patients were women, and 8 (34.8%) of the patients were men. The mean age was 61.9 ±13.5. Seventeen (74%) of the patients had abdominal pain. Twenty 
(87%) of the patients had anticoagulant and antiplatelet therapy.The mean hematoma diameter was 6.3± 3.6 cm. The mean APACHE II score for the patients 
was 13.1±7.3. One patient had undergone surgery. There was mortality in 3 (13%) of the patients. The median length of stay in hospital was 5 (5) days. Discus-
sion: The diagnosis of rectus sheath hematoma should be kept in mind while assessing old female patients and patients on anticoagulants with a complaint 
of abdominal pain. In our study, we identify risk factors such as higher APACHE –II scores, the presence of a transient ischemic attack, need for transfusion of 
more units of packed erythrocytes and more extended hospital stay as factors associated with mortality.
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Introduction
Rectus sheath hematoma (RSH) is a rare clinical condition that 
is caused by the occurrence of hematoma in rectus muscle or 
within muscle sheath following the injury to the branches of the 
superior epigastric artery. RSH could be observed after blunt 
or penetrating abdominal trauma, vigorous exercise, recent 
abdominal surgery, at trocar sites after laparoscopic surgery, 
abdominal wall injections, paracentesis or it could occur spon-
taneously in the presence of predisposing factors such as an-
ticoagulation therapy and intractable coughing [1]. RSH could 
also mimic appendicitis or sepsis [2].
There are well-defined predisposing factors, clinical features, 
diagnostic classification by abdominal computerized tomogra-
phy (CT) and treatment options for RSH in the literature [3]. 
However; there is lacking consensus about RSH related mortal-
ity and risk factors affecting mortality in patients with RSH.
We aimed to investigate risk factors that influence mortality 
in patients with RSH primarily. The secondary purpose of this 
study is an overview of clinical characteristics, diagnosis mo-
dalities, treatment options and results of the patients with RSH.
Material and Method
Twenty-three patients with rectus sheath hematoma from 
January 2012 to March 2017 in a tertiary care center were 
included in the study. Patients’ files were reviewed retrospec-
tively. Exclusion criterion was pediatric age group (0-16 years 
old) patients. We described 54 variables such as age, gender, 
symptoms, and clinical findings of the patient, co-morbidities, 
medications, laboratory findings, diagnostic modality, CT clas-
sification, hematoma side, the diameter of hematoma, Acute 
Physiology and Chronic Health Evaluation (APACHE)- II score 
at the time of diagnosis, treatment options, transfused blood 
products, length of hospital stay (LOS) and presence of mortal-
ity after reviewing the files. 
We composed two independent groups due to the presence or 
absence of mortality to assess possible risk factors. IBM SPSS 
statistic software version 24.0 (IBM Corp., Armonk, NY, USA) 
was used for statistical analyses. Shapiro-Wilk test was applied 
to determine the distribution of normality. Normally distributed 
quantitative variables were expressed as the mean ± standard 
deviation (SD), quantitative variables not normally distributed 
were expressed as median with interquartile range and cate-
gorical variables as frequency and percentage. Student-t-test 
was applied to normally distributed quantitative variables of 
independent groups. Mann-Whitney U test was used for quan-
titative variables without normally distributed data of separate 
groups. Chi-square test was applied to categorical variables. 
Logistic regression model was carried out for multivariate 
analyses. A value of p< 0.05 was considered as statistically sig-
nificant.
This study was approved by Baskent University Institutional Re-
view Board (Project no: KA17/132)
Results
A total of the 23 patients, 65.2% were women, and 34.8% were 
men. The mean age was 61.9± 13.5 years (range 31 – 87 years). 
87% of the patients had at least one co-morbid disease. 87% 
of the patients were receiving anticoagulant or antiplatelet 
therapy, and 34.8% of patients were receiving both anticoagu-
lant and antiplatelet therapy. RSH developed at trocar site after 
laparoscopy in three of the patients (13%), due to paracentesis 
in two of the patients (8.7%) and after blunt abdominal trauma 
in one of the patients (4.3%). One patient was pregnant. Con-
servative treatment was chosen for 20 (87%) of the patients; 
transcatheter embolization was performed for two (8.7%) of 
the patients, and one (4.3%) patient was operated on. Patients’ 
clinical features are shown in Table 1 and Table 2.
Mortality rate was 13%. The mean age was 53.3±7.5 (range 
48- 62), the mean Co-morbid disease numbers were 3.3± 1.1 
(range: 2- 4), the mean APACHE-II score was 27 ±4.5 (range: 23- 
32), the median transfused packed erythrocytes units were 9(0) 
(Range: 6- 16 units), the median LOS days were 11(0) (range: 
8- 21 days) in mortality group.  Conservative management was 
utilized for two of the patients and surgery was selected for one 
patient in the group.
We detected a significant difference between mortality and 
APACHE –II scores, the presence of a transient ischemic attack, 
LOS, and transfused units of packed erythrocytes.
Table 1. Categorical variables of the Patients
Variables Values n (%)
Gender
Women 15 (65.2%)
Men 8 (34.8%)
Symptoms and Findings
Abdominal Pain  17 (73.9%)
Ecchymosis 13 (56.5%)
Intractable Coughing 6 (26.1%)
Abdominal Mass 11 (47.8%)
Nausea 2  (8.7%)
Vomiting 2 (8.7%)
Fever 3 (13%)
Tenderness 16 (69.6%)
Rebound 9 (39.1%)
Hematoma Side
Right 8 (34.8%)
Left 14 (60.9%)
Bilateral 1 (4.3%)
Co-morbid Disease
Present 20 (87%)
Absence 3 (13%)
Anticoagulant or Antiplatelet Therapy
Present 20 (87%)
Absence 3 (13%)
Hematoma Type
Type 1 6 (26.1%)
Type 2 12 (52.2%)
Type 3 5 (21.7%)
Treatment
Conservative 20 (87%)
Transcatheter Embolization 2 (8.7%)
Surgery 1 (4.3%)
Mortality 3 (13%)
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Discussion
We investigated factors affecting mortality and overviewed 
clinical features in the patients with RSH  in this retrospective 
study. We found that mortality rate is 13% and this ratio is 
compatible with the literature. The mortality rate of the largest 
case series of 126 patients from Mayo Clinic was 1.6% [4]. The 
mortality rate in patients with RSH ranges from 0% to 14.7 
% in various studies [5]. Villa et al. [6]reported that mortality 
rate was 17% among the patients who had to undergo sur-
gery because of the hemodynamic instability of the patients. 
Carkman et al. [7]stated that the mortality rate could reach 
20% in elderly and patients receiving anticoagulant therapy 
presenting with RSH. In this univariate analysis, we found that 
higher APACHE- II scores, the presence of TIA, need for more 
erythrocytes transfusion, and longer LOS are associated with 
the occurrence of mortality. We could not reveal significant dif-
ferences between mortality and any variable in the multivari-
ant analysis. While the median units of transfused erythrocytes 
were 3.5 units in the previous study [4], our patients needed 
more erythrocytes transfusion (the median is nine units). The 
length of stay in hospital ranges from 4 to 10 days in previous 
studies [8]. In our study, the median LOS was 11 days in mortal-
ity group and 4.5 days in surviving group. We think that patients 
had to limit physiologic conditions beforehand resulting in more 
transfusions and longer stay in hospital in mortality group.
Higara et al. [9] reported that mortality rate was 0.28% in isch-
emic stroke patients with RSH and they indicated that patients 
were receiving both antiplatelet and anticoagulant therapy. In 
our study, mortality occurred in two of the three TIA patients. 
While one of the mortality cases was receiving both antiplatelet 
and anticoagulant therapy, the other patient was receiving only 
anticoagulant therapy. However, we could not derive a relation 
between mortality and anticoagulant therapy.
We noted that women to men ratio was 1.8:1 and is compatible 
with previous studies, nevertheless, we could not reveal any ad-
ditional risk factor for female patients with RSH. 
The range of age was 46 – 69 years in previous research [10] 
and the mean age was 61.9 ±13.5 (range: 31-87) in our study. 
Patients developing RSH are mostly elderly, and this could be 
explained with these elderly patients being more liable to be on 
anticoagulant therapy. We also found lower INR levels than the 
previous study [4].
CT scan was performed for all patients except the pregnant 
one. CT scan is widely accepted as first-line diagnostic modal-
ity because of its superiority to ultrasound. Because it reveals 
hematoma size, location, and relation with peritoneum, CT scan 
could aid in shortening time for surgical decision-making pe-
riod. 
Most of the RSH patients were treated conservatively, that 
includes nil per os, intravascular hydration, bed rest and ad-
ministering analgesics. Transcatheter embolization was per-
formed for two patients, and surgery for hematoma drainage 
with bleeding control was conducted for one patient.  Surgical 
decision-making depends on the hemodynamic instability of the 
patient with RSH [6]. Scoring systems such as APACHE- II could 
be used to decide which patient to take to surgery before devel-
oping hemodynamic instability.
The study has some limitations: its retrospective in nature, a 
tertiary center analysis and a small number of patients that 
could have resulted in findings of higher mortality rate.
In conclusion, there are various predisposing factors for RSH. 
RSH should be kept in mind while evaluating geriatric female 
patients and patients on anticoagulant with a complaint of ab-
dominal pain. Furthermore, we note that risk factors such as 
higher APACHE –II scores, the presence of TIA, transfusion of 
more units of packed erythrocytes and longer hospital stays are 
associated with an increase in mortality.
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Table 2 Quantitative variables of the patients
Variables Values
Age 61.9 ± 13.5
Number of Co-morbid diseases 3 (2)
APACHE-II Score 12 (10)
Diameter of the hematoma (cm) 6.3± 3.6
Hemoglobin level (g/dl) 9.3±2.2
Thrombocytes (x103) 248 (122)
White blood cell (x103) 9.3(7.5)
INR level 1.35 (1.44)
Transfused erythrocytes (units of 
package)
0 (5)
Transfused FFP ( units of package) 0(1)
Length of hospital stay (day) 5 (5)
INR: International normalized ratio; FFP: Fresh Frozen Plasma
Table 3. Comparison of variables in patients with or without mortality
Variables Mortality P value
Present Absence
Age 53.3±7.5 63.2±13.9 0.2
Co-morbid disease number 4(0) 3(3) 0.8
Hematoma diameter (cm) 8.7±4 6.1±3.5 0.3
Hemoglobin (g/dl) 8.2±2.9 9.5±2.2 0.3
WBC (x10
3
) 9.3(0) 9.1(8.2) 1
Thrombocytes (x10
3
) 266(0) 241(132) 0.4
INR 1.6(0) 1.2(1.5) 0.4
Erythrocytes (Unit of packages) 9(0) 0(2) 0.001*
FFP (Unit of packages) 26(0) 0(1) 0.1
APACHE II score 26(0) 11(9) 0.001*
Length of hospital stay (days) 11(0) 4(3) 0.012*
WBC: White blood cell; INR: International normalized ratio; FFP: Fresh frozen 
plasma
*Statistically significance
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